Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.

The global Animal Antibacterial Peptide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025.
This report focuses on Animal Antibacterial Peptide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Animal Antibacterial Peptide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Animal Antibacterial Peptide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Animal Antibacterial Peptide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Anionic Peptides
Anionic & Cationic Peptides
Cationic Peptide
Linear Cationic - Helical Peptides

Segment by Application
Sheep
Pig
Cattle
Horse
Poultry
Goat